• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » James Brown elected to Safe-Biopharma board of directors

James Brown elected to Safe-Biopharma board of directors

February 14, 2014
CenterWatch Staff

SAFE-BioPharma Association, the nonprofit collaboration that developed and manages the global SAFE-BioPharma digital identity and digital signature standard, has elected James W. Brown, Ph.D., chief operating officer, Regenx Biosciences to its board of directors.

The SAFE-BioPharma standard is used throughout the biopharmaceutical and healthcare industries to manage digital identity trust and to apply legally binding digital signatures to electronic documents. It is a strategic initiative of the life sciences industry to facilitate secure, trusted and fully electronic business and regulatory processes. The association’s members include most of the world’s largest biopharmaceutical companies. 

Based in Washington, DC, Regenx is a personalized gene therapy company focused on unmet needs of a variety of severe diseases. Before joining Regenx, Brown was responsible for IT strategy and project portfolio for R&D at MedImmune. He also worked in a variety of IT leadership roles in other life science companies. Previously, Brown was a National Research Council Postdoctoral Fellow at the National Institutes of Standards and Technology (NIST).

SAFE-BioPharma Association has an all-volunteer board which determines the association's  strategic direction and business model, and oversees its management. Among numerous recent initiatives are global expansion of the standard through integration with biopharmaceutical and healthcare industry applications such as signing engines, portal providers, clinical trial applications, ePrescribing, access to eHRs and other critical digital workflows.

Upcoming Events

  • 17May

    Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing